REVIEW article
Front. Aging Neurosci.
Sec. Alzheimer's Disease and Related Dementias
Volume 17 - 2025 | doi: 10.3389/fnagi.2025.1623050
This article is part of the Research TopicMolecular mechanisms of neurodegenerationView all 16 articles
Elucidating Molecular Pathogenesis and Developing Targeted Therapeutic Interventions for Cerebrovascular Endothelial Cell-Mediated Vascular Dementia
Provisionally accepted- 1Department of Pharmaceutical Analysis, School of Pharmacy, Ningxia Medical University, Yinchuan, China
- 2Key Laboratory of Ministry of Education in Protection and Utilization of Medicinal Resources of Liupanshan Area, Ningxia Medical University, Yinchuan 750004, Ningxia, China, Yinchuan , Ningxia, China, China
- 3The First Aaffiliated Hospital of Hainan Medical University, Haikou 570100, Hainan, China, Haikou , Hainan, China, China
- 42. Key Laboratory of Ministry of Education in Modernization of Minority Medicine, Ningxia medical University, Yinchuan 750004, Ningxia, China, Yinchuan , Ningxia, China, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Abstract:Vascular dementia (VaD) ranks as the second most prevalent subtype of dementia, surpassed only by Alzheimer's disease (AD). The maintenance of neurological function and cerebral homeostasis critically depends on precisely regulated blood flow within the intricately organized cerebrovascular network.may impair neurovascular homeostasis, thereby inducing pathophysiological cascades characterized by oxidative stress, neuroinflammation, and neuronal degeneration. Emerging evidence identifies cerebrovascular dysregulation and impaired neurovascular coupling (NVC) as primary pathogenic mechanisms underlying VaD, emphasizing the necessity to elucidate their complex interplay. Cerebrovascular endothelial cells exhibit remarkable heterogeneity, serving dual roles as both architectural components of the blood-brain barrier (BBB) and functional regulators of NVC. Furthermore, pericytes residing abluminal on capillary endothelia demonstrate critical involvement in hemodynamic modulation through contractile regulation of microvascular tone, while concurrently maintaining BBB integrity through dynamic paracrine signaling. This study examines cerebrovascular endothelial-neuronal interactions within the neurovascular unit (NVU) framework, analyzing their bidirectional regulatory mechanisms and therapeutic potential in cognitive dysfunction remediation. The pathophysiological progression of VaD manifests through multiple interdependent pathways, including cerebral hypoperfusion, oxidative stress cascades, neuroinflammatory responses, mitochondrial dysregulation, and electrolyte homeostasis perturbations. Through three interventional axes: (1) BBB fortification strategies; (2) cerebral hemodynamic optimization and NVC enhancement; (3) nanotherapeutic platforms integrating endothelial-specific molecular targets we systematically evaluate endothelial-centric therapeutic paradigms. This multi-modal approach proposes novel mechanistic insights and clinical translation frameworks for VaD management.
Keywords: Vascular Dementia, neurovascular coupling, Cerebrovascular endothelial cells, Molecular mechanisms, Treatment and Strategy
Received: 05 May 2025; Accepted: 02 Jul 2025.
Copyright: © 2025 Yang, Chen, Liu, Niu and WANG. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Yang Niu, 2. Key Laboratory of Ministry of Education in Modernization of Minority Medicine, Ningxia medical University, Yinchuan 750004, Ningxia, China, Yinchuan , Ningxia, China, China
Rui WANG, Department of Pharmaceutical Analysis, School of Pharmacy, Ningxia Medical University, Yinchuan, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.